Connect with us

Altcoins

Encrypgen (DNA) Launches World’s First Blockchain Genomic Data Marketplace

Published

on

Encrypgen
READ LATER - DOWNLOAD THIS POST AS PDF

Crypto investors have had an extremely rough year.  Losses have been massive and it’s unclear when the bear market will end.  One of the biggest reasons behind the precipitous drop in token prices has been due to companies not achieving what they promised.  At some point investors need results.  One company that is bucking that trend is Encrypgen (DNA).  Back in August, Encrypgen launched the beta version of its Gene-Chain.  And now today, Encrypgen will officially launch version 1 of the world’s first blockchain genomic data marketplace.

Back in August, when the beta version of the Gene-Chain was launched, the DNA token price soared by approximately 60% at its highest point.  And that was just a beta version.  It’s very possible that the launch of Gene-Chain version 1 will cause an even bigger spike.  And that’s because of a new feature called “buy now.”

The DNA token is a utility token.  In a nutshell, that means that the value of the token will be determined by real-world usage.  With the implementation of the buy now feature, researchers and scientists will be able to purchase DNA tokens directly on the platform.  Those DNA tokens will come directly from Encrypgen’s inventory of approximately 3 million.  As that supply diminishes, Encrypgen will then have to go to the exchanges, such as Cryptopia and Kucoin, to buy more tokens.  Another possibility is that researchers will bypass the company and just go directly to the exchanges to buy tokens.  Either way, it’s clear that Encrypgen has reached the point of utility and traders can begin to expect a significant run-up in the token price.

Because DNA is a utility token, there are two important questions for investors.  First, what does the competitive landscape look like?  And second, what does the industry look like?

Competitors

As mentioned earlier, Encrypgen has now launched the world’s first genomic data marketplace.  So, while there are some competitors, they are years behind.  The main competitors include LunaDNA, Nebula Genomics, and Shivom.

LuncaDNA: Luna is no longer interested in a cryptocurrency.  Instead, they have decided to award shares in a public benefit corporation to data donors.  While it’s probably a safe move from a regulatory point of view, I think it’s a bad long-term plan.  A spendable currency is significantly more valuable than shares.  Cryptocurrencies offer anonymity while shares do not.  And further, Luna has yet to announce any sort of timeline for its platform.

Nebula Genomics: Nebula has managed to build an impressive company with one of the best teams in the business.  The company is promising to use blockchain but has oddly decided against doing an ICO (at least for now).  Instead, they will likely do a token generation event with a minimum required purchase of $50,000 (leaked via Telegram).  The founder of Nebula, George Church, is well respected in the industry.  However, there is a potential conflict of interest.  Mr. Church owns a sequencing company called Veritas.  The tokenomics model is questionable and it’s unclear how Nebula plans to make money.  Therefore, it’s entirely possible that Nebula’s purpose is to help sell Veritas tests.  Great for Mr. Church but not all that wonderful for investors.

Shivom: Although Shivom was able to raise a great deal of money in their ICO, the company has some issues.  First, a company that helped promote the sale in Australia is facing a $2 million lawsuit.  Second, Shivom’s registered agent in the Isle of Man has resigned.  Third (and most importantly), Shivom has yet to even produce an alpha platform.

As traders can see, these 3 competitors above certainly should be acknowledged but there doesn’t appear to be much cause for concern.  Encrypgen is certainly the undisputed leader of blockchain genomics at this point.

Industry Strength

Genomics is currently one of the hottest spaces around and is forecasted to grow to at least $24 billion by the year 2022.  This number has already been revised upward several times so it’s entirely possible that the $24 billion is at the low end of expectations.  The industry growth will be driven by an increase in genomic research activities, a rising number of start-up companies, a growing focus on personalized medicine, and an increasing application of genomic sequencing in the diagnostics.

Conclusion

Most traders in the crypto space recognize that only a few of the current cryptocurrencies will exist in 5-10 years.  The ones that deliver will grow exponentially and the ones that don’t will fizzle out quickly.  Traders should be looking for companies that have delivered on their promises and have real-world usage.  Encrypgen checks all the boxes.

Disclosure: I am long DNA

For real-time trade alerts and a daily breakdown of the crypto markets, sign up for Elite membership!

Disclaimer: This article should not be taken as, and is not intended to provide, investment advice. Global Coin Report and/or its affiliates, employees, writers, and subcontractors are cryptocurrency investors and from time to time may or may not have holdings in some of the coins or tokens they cover. Please conduct your own thorough research before investing in any cryptocurrency and read our full disclaimer.

Image courtesy of Pexels

Altcoins

Encrypgen’s New HODLING Incentive Program May Send DNA Token Soaring

Published

on

Encrypgen
READ LATER - DOWNLOAD THIS POST AS PDF

Cryptocurrency traders have enjoyed a Bitcoin moon shot during the past few months.  Those gains have created a much more enjoyable environment for crypto bulls.  Whether it’s a temporary or permanent increase remains to be seen but hitting the 10,000 level has put everyone in a better mood.  Unfortunately, altcoins have not had experienced the same type of gains and are lagging significantly behind Bitcoin.

I’ve written articles in the past year that there is at least a decent chance that many altcoins won’t survive the current environment.  The ones that do will do so because they created a platform that has real world usage.  After spending countless hours researching many of the existing altcoins, I’ve yet to see a company that is more promising than Encrypgen (DNA).

Encrypgen Background Information

Encrypgen is a genomic blockchain network that provides customers and partners with best-in-class, next generation, blockchain security for protecting, sharing and re-marketing genomic data. This creates a fair marketplace for a person’s DNA that can be stored privately and sold (if a person wishes to do that). A person’s DNA can also be shared privately and securely with their physician for their personalized care.

Typically, people can send their DNA off to a lab to find out who they are and where they come from. As fun as that might sound, there is a significant security problem…

Continue Reading

Altcoins

Top 3 Coins to Buy Before They Go Big

Published

on

coins
READ LATER - DOWNLOAD THIS POST AS PDF

Crypto bulls are back, that much is clear. The long-lasting, harsh crypto winter is gone, and the new era in digital currency sector opens up some rather interesting opportunities. With many more bull runs expected to come in months ahead, a lot of coins are likely to blow up and maybe even hit new all-time highs, although that still remains purely theoretical.

On the other hand, the fact is that numerous coins are seeing prices that were not achieved since early 2018, and the overall momentum remains bullish. With that in mind, even if new records do not come for a very long time — chances are that many of the coins will blow up enough for investors to see some serious gains in months to come. As a result, investing in some of these coins now might be a very profitable decision, for those who have the patience to wait a few months. Here are some of the projects believed to have the greatest potential to go big in the second half of 2019 and beyond.

1. TRON (TRX)

Putting TRON on the list should not really surprise anyone, as the project constantly comes up with new project updates, partnerships, and alike. It also constantly breaks records, as is becoming one of the biggest players in the dApp and smart contract development sector.

In the past few…

Continue Reading

Altcoins

TRON (TRX) Is Likely to Go Big in June

Published

on

Tron
READ LATER - DOWNLOAD THIS POST AS PDF

We are now halfway through 2019, and the situation in the crypto space is better than ever in the past year. Numerous cryptos are seeing large gains, often cut by brief periods of stagnation or small corrections, but the overall sentiment is obviously bullish.

Bitcoin sits way above the $8k mark, and while it struggles to go beyond $8,700, it is still trying to grow. Investors and analysts are quite bullish regarding the foreseeable future, and a lot of altcoins are expected to follow BTC in this regard. However, today, we would like to talk about one particular altcoin — TRON (TRX) — as well as why it is likely to go big in June.

TRON’s progress so far

As many people in and out of TRON community know, TRX is not a project that often sits still. It is rich with announcements, particularly when it comes to his CEO, Justin Sun, whose enthusiastic tweets often seem like hype building to many.

However, TRON made some massive progress in 2018, which was the worst year cryptocurrencies have ever seen. This is not something that can be achieved through hype alone, and the project needs to have true quality and value in order to see such massive development in the middle of the longest and harshest crypto winter in…

Continue Reading

Elite